Tag Archives: Supreme Court of India

India: Investment treaties stifle public policy objectives

Posted on April 28, 2012 by

Source: SUNS #7357 dated 25 April 2012 New Delhi, 24 Apr (K. M. Gopakumar*) — Investment treaty provisions can stifle the Indian government’s effort to address public policy objectives, as seen from a recent spate of challenges by foreign investors. … Continue reading →

Posted in BITS, investor state dispute | Tagged , | Leave a comment

Press Statement: NOVARTIS LIES THREATEN OUR LIVES ACT UP-BASEL LAUNCHED TO DECLARE THE WAR ON PHARMA

Posted on October 17, 2011 by

● Press Statement ● ACT UP-BASEL ● Sunday the 16th October 2011 http://actupbasel.org/actupbasel/ BASEL, SWITZERLAND – Tomorrow in New Delhi, the next hearing of the case brought by the Basel-based pharmaceutical firm Novartis against the Indian government is scheduled to … Continue reading →

Posted in patent evergreening, Sec 3 (d), TRIPS | Tagged , , , , | Leave a comment

Lawyers Collective-Novartis update: Supreme Court to hear arguments on maintainability of Novartis’ petition to Supreme Court

Posted on October 7, 2011 by

26 September 2011, New Delhi Novartis’ Special Leave Petition (SLP) challenging the decision of the Intellectual Property Appellate Board (IPAB) rejecting its appeal for a patent on the beta-crystalline form of imatinib mesylate, an anti-cancer drug, was listed for hearing … Continue reading →

Posted in patent evergreening, Sec 3 (d) | Tagged , | 1 Comment

MSF Briefing Note: WHAT NOVARTIS SAYS…AND WHY IT’S WRONG

Posted on October 5, 2011 by

Médecins Sans Frontières briefing note, 4 October 2011  Swiss pharmaceutical company Novartis issued a press statement last week in response to the growing concerns regarding its latest legal challenge against the Indian government. Ahead of the next hearing of the … Continue reading →

Posted in Indian Patent Law, patent evergreening, Sec 3 (d) | Tagged , , , | 1 Comment

Press Release: Novartis attempts to weaken Indian Patent Law that threatens to restrict access to live-saving medicines for millions in the developing world

Posted on September 29, 2011 by

Act Up -Paris Press Release This afternoon, Act Up-Paris protested in front of Novartis-France headquarters in Rueil Malmaison, a town near Paris. The activists blocked the entrance of the building and shut the gate. They unfurled a banner which said … Continue reading →

Posted in patent evergreening, Sec 3 (d), TRIPS plus | Tagged , , | Leave a comment

Stephen Colbert on faux innovation by pharma companies to extend patents

Posted on September 19, 2011 by

We have been posting many articles on Novartis case in Supreme Court challenging Section 3(d) of Indian patent law which inhibits patent evergreening. Here is an interesting video that explains evergreening of patents by pharmaceutical companies in a very funny way. It … Continue reading →

Posted in patent evergreening, Sec 3 (d) | Tagged , , , | Leave a comment

Analysis: Legal case in India threatens HIV drug access for poorest

Posted on September 13, 2011 by

September 12th, 2011 | by Melanie Newman Source: The Bureau of Investigative Journalism A technical case going through the Supreme Court in India is being carefully watched by aid agencies and other human rights organisations, who claim it could have severe … Continue reading →

Posted in Indian Patent Law, patent evergreening, Sec 3 (d), TRIPS plus, Uncategorized | Tagged , , | Leave a comment

Novartis Must Not Win This Case

Posted on September 12, 2011 by

Amit Sen Gupta, 10-Septmber-2011 Source: Newsclick Capital is as terrified of the absence of profit or a very small profit as nature is of a vacuum. With suitable profits, capital is awakened; with 10 percent, it can be used anywhere; … Continue reading →

Posted in Generic drug, HIV/Aids, Indian Patent Law, patent evergreening, Sec 3 (d) | Tagged , , , , , | Leave a comment

Indian Supreme Court To Hear Novartis Challenge To India’s Patent Law

Posted on September 6, 2011 by

Indian Supreme Court To Hear Novartis Challenge To India’s Patent Law By William New, Intellectual Property Watch 06/09/2011 @ 5:21 am The Indian Supreme Court today is expected to hear Swiss pharmaceutical company Novartis’ case against a provision of Indian … Continue reading →

Posted in Indian Patent Law, patent evergreening, Sec 3 (d), TRIPS plus | Tagged , , , | 3 Comments

Drug company Novartis tries to weaken Indian patent law that protects people

Posted on September 5, 2011 by

  Geneva/New Delhi 5 September 2011 – Novartis will go before the Indian Supreme Court tomorrow in the latest attempt by the Swiss multinational pharmaceutical company to undermine a key public health safeguard in Indian patent law specifically designed to prevent … Continue reading →

Posted in Indian Patent Law, Sec 3 (d), TRIPS plus | Tagged , , , , | Leave a comment